# Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/inhibition-of-mmp-2-expression-enhances-the-antitumor-effect-of-sorafenib-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wenliang Tan,Sicong Zhu,Jun Cao,Lei Zhang,Wenda Li,Kairui Liu,Jinyi Zhong,Changzhen Shang,Yajin Chen |
| Citations | 30 |
| DOI | 10.3727/096504017x14886444100783 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.3727/096504017x14886444100783 |
| OpenAlex ID | https://openalex.org/W2593042761 |
| PMID | 28276313 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Wenliang Tan](https://scholariq.org/researchers/wenliang-tan/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.